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ignals transduced by kinases depend on the extent
and duration of substrate phosphorylation. We gener-
ated genetically encoded ﬂuorescent reporters for
PKC activity that reversibly respond to stimuli activating
PKC. Speciﬁcally, phosphorylation of the reporter expressed
in mammalian cells causes changes in ﬂuorescence reso-
nance energy transfer (FRET), allowing real time imaging of
phosphorylation resulting from PKC activation. Targeting of
the reporter to the plasma membrane, where PKC is activated,
reveals oscillatory phosphorylation in HeLa cells in response
to histamine. Each oscillation in substrate phosphorylation
follows a calcium oscillation with a lag of 
 
 
 
10 s. Novel
S
 
FRET-based reporters for PKC translocation, phosphoinositide
 
bisphosphate conversion to IP
 
3
 
, and diacylglycerol show
that in HeLa cells the oscillatory phosphorylations correlate
 
with Ca
 
2
 
 
 
-controlled translocation of conventional PKC
to the membrane without oscillations of PLC activity or
diacylglycerol. However, in MDCK cells stimulated with
 
ATP, PLC and diacylglycerol ﬂuctuate together with Ca
 
2
 
 
 
and phosphorylation. Thus, speciﬁcity of PKC signaling
depends on the local second messenger-controlled equi-
librium between kinase and phosphatase activities to result
in strict calcium-controlled temporal regulation of substrate
phosphorylation.
 
Introduction
 
Dynamic interplay between phosphorylation and dephos-
phorylation critically controls cellular function. This is
particularly evident in signal transduction, where the extent
and duration of substrate phosphorylation dictates the nature of
downstream signaling. Perturbation of the balance between
phosphorylation and dephosphorylation can alter a cell’s
fate, from triggering apoptosis to promoting proliferation.
Since its discovery over two decades ago as the “phorbol
ester receptor” (Nishizuka, 1984), PKC has been known to
play a key role in maintaining the balance between normal
growth and transformation (Nishizuka, 1995). Indeed, the
tumor-promoting properties of phorbol esters exemplify the
cellular consequences of tipping the balance of cellular signals
excessively toward phosphorylation. PKC function in cells is
exquisitely controlled by three major mechanisms: phosphory-
lation, required for catalytic competence, membrane targeting,
required for conformational activation, and protein–protein
interactions, which poise the enzyme at specific intracellular
locations (Mellor and Parker, 1998; Newton, 2002b). Thus,
PKC activity is dependent on the spatiotemporal context of
the enzyme, its substrates, and its activating cofactors. Pertu-
bation of any of these mechanisms disrupts cell function by
altering the degree of substrate phosphorylation.
There are 10 mammalian PKC isozymes that share a
highly homologous catalytic domain, conferring relatively low
substrate selectivity between family members (Nishikawa et
al., 1997). All isozymes contain an autoinhibitory pseudosub-
strate sequence in the regulatory moiety that allosterically
regulates access of substrates to the active site. In addition,
the regulatory moiety contains one or two membrane-target-
ing modules: the C1 domain, which binds diacylglycerol
(DAG)* and phorbol esters, and the C2 domain, which
binds Ca
 
2
 
 
 
. Conventional PKC isozymes (
 
 
 
, 
 
 
 
I, 
 
 
 
II, and 
 
 
 
)
have functional C1 and C2 domains and are thus stimulated
by DAG and calcium. Novel PKC isozymes (
 
 
 
, 
 
 
 
, and 
 
 
 
)
have a functional C1 domain but nonligand binding C2
domain and are stimulated by DAG but insensitive to calcium.
Atypical PKC isozymes (
 
  
 
and 
 
 
 
/
 
 
 
) have a nonligand binding
C1 domain and no C2 domain and are thus not regulated
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*Abbreviations used in this paper: AKAR, A kinase activity reporter;
CICR, calcium-induced calcium release; CKAR, C kinase activity reporter;
CYPHR, cyan/yellow PH domain reporter;
 
 
 
DAG, diacylglycerol; DAGR,
 
DAG receptor; FRET, fluorescence resonance energy transfer; IP
 
3
 
, inositol
1,4,5-trisphosphate; mCFP, monomeric CFP; mYFP, monomeric YFP;
MyrPalm, myristoylated and palmitoylated; PDBu, phorbol dibutyrate;
PIP
 
2
 
, phosphoinositide bisphosphate.T
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by either of these second messengers. Additional isozyme-
specific regulation is provided by protein–protein interac-
tions that tether PKC near its substrates (Mochly-Rosen,
1995; Jaken and Parker, 2000). Because PKC is activated
through many different receptor types that couple to phos-
pholipid hydrolysis with or without calcium release, there is
potential for a wide range of amplitude and duration of
PKC signals.
The translocation of PKC from the cytosol to the mem-
brane has served as the hallmark for PKC activation since the
seminal discovery that phorbol esters cause PKC to redistrib-
ute from the cytosol to the membrane (Kraft et al., 1982;
Kraft and Anderson, 1983). Recent advances have taken ad-
vantage of GFP to visualize translocation of PKC to mem-
branes upon generation of DAG and calcium in living cells.
(Sakai et al., 1997; Oancea and Meyer, 1998; Shirai et al.,
1998b). These studies have revealed a wealth of information
on the kinetics and localization of PKC inside the cell. It is
not clear, however, to what extent PKC translocation corre-
sponds to PKC activation and substrate phosphorylation.
The study of complex signaling systems in living cells has
become possible with advances in fluorescent reporters. Sig-
naling events can be monitored by either fluorometric
chemical chelators such as the calcium dyes (Tsien, 1989)
or genetically encoded fluorescent proteins engineered to
change either subcellular location or fluorescent properties
upon sensing cellular signals. Numerous examples now exist
of fusions of fluorescent proteins to either translocating sig-
naling domains such as C1, C2, and PH domains (Oancea
et al., 1998; Gray et al., 1999) or proteins that contain
these domains (Sakai et al., 1997; Gijon et al., 1999). Addi-
tionally, a growing number of reporters have been designed
that alter fluorescence resonance energy transfer (FRET)
between fluorescent proteins (Miyawaki and Tsien, 2000)
or the intrinsic fluorescent properties of a fluorescent pro-
tein (Llopis et al., 1998; Nagai et al., 2001). Reporters
based on FRET between fluorescent proteins have several
advantages: unlike small molecule reporters, they are genet-
ically encodable, and unlike translocation indicators, they
require simple optics and software to analyze. Additionally,
a FRET reporter may be pretargeted to subcellular sites if
translocation is not an integral part of the readout. Thus,
much information can be gleaned from living cells, pro-
vided that such reporters do not significantly perturb cell
function (for example, by buffering of cell signals resulting
from reporter overexpression) and provided reporter speci-
ficity is maintained in cells.
Recent work has shown that FRET reporters for kinase
activity are a viable method to probe phosphorylation in
live cells (Ting et al., 2001; Zhang et al., 2001; Sato et al.,
2002). We developed a reporter for phosphorylation by
PKC that we call C kinase activity reporter (CKAR) and
used this in conjunction with calcium-sensing fluoro-
phores and novel FRET-based translocation assays to test
the spatiotemporal properties of the PKC signal pathway.
We find a surprisingly high temporal fidelity of signaling
restricted to the plasma membrane, controlled by the tem-
porally limiting (i.e., fastest changing) second messenger
calcium, and dependent on a strict coupling of kinase and
phosphatase activities.
Figure 1. Generation of CKAR. (A) CKAR is comprised of mCFP, 
the FHA2 domain of Rad53p, a PKC substrate sequence, and 
mYFP. The substrate sequence, when phosphorylated, binds the 
FHA2 phospho-peptide–binding domain. This conformational 
change results in a change in FRET, reversible by phosphatases. 
(B) CKAR is stoichiometrically phosphorylated by PKC in vitro. 
Time course of 
32P incorporation into nickel-purified histidine-
tagged CKAR measured by scintillation counts of excised Coomassie 
blue–stained bands. (Inset) Coomassie blue–stained purified CKAR 
(top) and 
32P autoradiography (bottom). (C) Emission spectra of 
CKAR incubated for 30 min at 30 C with and without purified 
PKC II. Excitation at 434 nm resulted in a CFP emission peak 
(476 nm) and YFP emission peak caused by FRET from CFP (528 nm). 
PKC phosphorylation resulted in decreased intensity at 528 nm and 
increased intensity at 476 nm, consistent with a decrease in FRET. 
Incubation of CKAR with trypsin for 30 min at 30 C destroyed the 
YFP emission, demonstrating that FRET was caused by intramolecular 
energy transfer. (D) Incubation with active calmodulin-dependent 
kinase II (CaMKII) or cAMP-dependent kinase (PKA) resulted in no 
change in FRET.T
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Results
 
Design and characterization of CKAR
 
A reporter for PKC-mediated phosphorylation, CKAR, was
constructed analogously to a previously described reporter
(A kinase activity reporter [AKAR]) for protein A (Zhang et
al., 2001). CKAR is composed of monomeric CFP (mCFP)
and monomeric YFP (mYFP) (Zacharias et al., 2002) flank-
ing a PKC substrate sequence tethered by a flexible linker to
an FHA2 phosphothreonine-binding domain from the yeast
checkpoint protein rad53p (Durocher et al., 2000) (Fig. 1
A). Phosphorylation of the PKC substrate sequence triggers
an intramolecular clamp with the FHA2 module, causing a
conformational change that alters the amount of FRET
from CFP to YFP (Fig. 1 A). This change in FRET provides
a continuous nondestructive fluorometric readout for CKAR
phosphorylation.
In designing CKAR, we focused on finding both an ap-
propriate phosphopeptide-binding domain and a specific
substrate sequence. We switched from the 14-3-3
 
 
 
 phospho-
serine-binding domain used in AKAR (Zhang et al., 2001)
to FHA2 for two reasons. 14-3-3
 
 
 
 is an obligate dimer,
whereas FHA2 is monomeric. Also, AKAR was a poor sub-
strate for phosphatases in living cells, perhaps because 14-
3-3
 
 
 
 binds phosphoserine too tightly and protects it from
phosphatases, whereas AKAR analogs with FHA1 could be
rapidly dephosphorylated upon cessation of PKA activity
(unpublished data). The dissociation constants of FHA1 and
FHA2 for their respective optimal peptides are 530 nM and
10 
 
 
 
M (Durocher et al., 2000), whereas 14-3-3 binds its
optimal peptide with a dissociation constant of 56 nM
(Yaffe et al., 1997) The modest affinity of FHA2 for phos-
phothreonine makes CKAR reversible and allows CKAR to
monitor the ongoing balance between PKC and phos-
phatases. We designed a specific PKC substrate sequence
that would also bind FHA2. This sequence was designed de
novo based on information from oriented peptide library
screens that have determined optimal substrate sequences for
all PKC isoforms (Songyang et al., 1994; Nishikawa et al.,
1997). We designed the substrate sequence based on three
criteria: (1) consensus phosphorylation sequence for PKC,
(2) minimal susceptibility to other basophilic kinases (Yaffe
et al., 2001), and (3) determinants that favor FHA2 bind-
ing. We decided upon the sequence GGSGGRFRRFQ-
TLKIKAKAGGSGG, where the underlined region is the
substrate sequence, flanked by a flexible linker sequence
GGSGG. This sequence is predicted to be an excellent sub-
strate for all PKC isoforms but suboptimal for all other ki-
nases (Nishikawa et al., 1997; Yaffe et al., 2001).
CKAR expressed in bacterial cells as a 6xHis-tagged fusion
construct was purified and tested for substrate specificity in
vitro. Fig. 1 B shows that CKAR was stoichiometrically
phosphorylated by PKC in a standard phosphorylation assay
using recombinant PKC 
 
 
 
II. In contrast, CKAR was not
phosphorylated by either CaMKII or PKA using standard
assays for these two kinases (unpublished data), even though
these two kinases are predicted to be the most likely alterna-
tives to phosphorylate CKAR (Yaffe et al., 2001).
Emission spectra of CKAR at the CFP excitation maxi-
mum (434 nm) before and after phosphorylation by PKC
 
(30 min) show a decrease of YFP emission (528 nm) and
concomitant increase in CFP emission (476 nm) upon phos-
phorylation (Fig. 1 C). Trypsinolysis of CKAR to cleave
CFP from YFP resulted in a dramatic loss of YFP emission,
confirming that the YFP emission peak in intact CKAR is
caused by intramolecular FRET (Fig. 1 C, blue line). In
contrast, emission spectra of CKAR before and after incuba-
tion in phosphorylation reactions with active PKA and
CaMKII showed no change (Fig. 1 D). Thus, specific phos-
phorylation of CKAR by PKC results in a decrease in FRET.
The absolute amounts of FRET can be estimated from Fig.
1 C to be 38% before and 34% after phosphorylation, as-
suming that emission at 476 nm arises solely from the CFP
donor and that FRET is negligible after trypsinolysis.
 
CKAR reports PKC activity in live cells
 
We next explored whether CKAR could function as a re-
porter for PKC in live cells. Fig. 2 A shows that CKAR ex-
pressed in MDCK cells showed a decrease in FRET upon ac-
tivation of PKC with phorbol dibutyrate (PDBu). Note that
the data in Fig. 2 A are plotted as the ratio of cyan fluores-
cence (which increases as FRET decreases) to yellow emission
(which decreases as FRET decreases). This decrease in FRET
was rapidly reversed by the specific PKC inhibitor Gö6983.
Treatment of MDCK cells with vehicle (DMSO) and then
forskolin to activate PKA did not alter the FRET ratio, indi-
cating that the sensor does not respond to PKA (Fig. 2 B, red
line). Similarly, no response was observed when cells were
first treated with Go6983 to inhibit PKC and then treated
with thapsigargin to stimulate CaMKII by calcium release
(Fig. 2 B, green line). These experiments performed in HeLa
cells yielded the same results (unpublished data). Thus,
CKAR senses PKC but not PKA or CaMKII activation in
live cells. We calibrated fluorescence intensity to protein con-
centration by imaging pure fluorescent protein of known
concentration to obtain a standard curve (unpublished data).
Based on this calibration, we estimate CKAR concentration
in cells to be 0.5–2 
 
 
 
M except where otherwise specified.
This is well within the range of concentration of endogenous
PKC substrates, which can be as high as 20 
 
 
 
M for abundant
proteins such as MARCKS (Wang et al., 2002).
We next tested whether full activation of PKC results in
complete phosphorylation of CKAR or if cellular phos-
phatases counteract PKC activity to maintain a significant
pool of unphosphorylated substrate. To maximally activate
PKC, we treated MDCK cells with 200 nM phorbol esters.
This resulted in a robust change in FRET (Fig. 2 C; red and
black lines are from two separate cells). Surprisingly, addi-
tion of the phosphatase inhibitor calyculin A (100 nM) to
cells already treated with 200 nM PDBu resulted in an even
larger increase in phosphorylation, indicating that maximal
PKC activation does not saturate CKAR unless phosphatases
are inhibited. This phosphorylation is compartmentalized:
PDBu results in preferential phosphorylation of CKAR in
the cytosol over the nucleus, the further increase in phos-
phorylation after calyculin A results in uniform phosphory-
lation throughout the cell (Fig. 2 D). Pseudocolored images
of this FRET change are shown in Fig. 2 E. Importantly,
similar results were observed with CKAR expression ranging
from 0.8 to 8 
 
 
 
M (unpublished data), indicating that sub-T
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strate buffering of PKC activity does not greatly alter CKAR
responses at the concentrations used in this work.
To confirm that changes in FRET result from phosphory-
lation of CKAR at the intended amino acid, we changed the
phosphoacceptor threonine in the PKC substrate sequence
to alanine. Fig. 2 F shows that this variant does not respond
to either PDBu or calyculin A, consistent with the designed
site of phosphorylation.
We next explored whether CKAR was sensitive enough to
respond to physiological activation of PKC. Fig. 2 G shows
that histamine treatment of HeLa cells resulted in a small
but reproducible change in FRET.
 
Membrane-tethered CKAR detects oscillations in 
substrate phosphorylation
 
We reasoned that because PKC activity is highest at mem-
branes, a membrane-targeted CKAR would be a better sub-
strate for PKC in intact cells. Thus, we fused the 10 NH
 
2
 
-
terminal residues of Lyn kinase to CKAR. This sequence
contains signals for myristoylation and palmitoylation
(Zacharias et al., 2002), effectively targeting CKAR to the
plasma membrane (Fig. 3 A). Fig. 3 B reveals that this
myristoylated and palmitoylated (MyrPalm)–CKAR under-
goes a FRET change upon treatment of HeLa cells with
PDBu similar to that observed for cytosolic CKAR. How-
ever, unlike cytosolic CKAR, the PDBu-induced FRET
change of the membrane-tethered CKAR was only modestly
sensitive to calyculin A (Fig. 3 B compared with Fig. 2 C).
Thus, tethering CKAR at the site of action of PKC alters
the phosphorylation/dephosphorylation equilibrium to fa-
vor phosphorylation.
We next examined the effect of receptor-mediated activa-
tion of PKC on membrane-tethered CKAR. Fig. 3 C shows
that in some cells histamine stimulation of HeLa cells trig-
gered a sustained series of transient phosphorylations. These
were terminated after 20 min by inhibition of PKC with 1
 
 
 
M Gö6983. Each phosphorylation “spike” displayed a
rapid rise followed by a slower decline (Fig. 3 D, expanded
time scale of C), consistent with a burst of kinase activity
followed by dephosphorylation to a baseline equilibrium be-
tween kinase and phosphatase activities. Oscillations were
extremely variable in amplitude, period, and duration, and
the data shown are representative of sustained, regular oscil-
lations seen in a minority of cells (5–10%). Either inhibition
 
Figure 2.
 
CKAR is a specific, reversible reporter for PKC activation 
in live cells. 
 
(A) CKAR expressed in HeLa cells is phosphorylated 
upon stimulation of PKC with 200 nM PDBu. This is reversed by 
addition of 500 nM Go6983, a specific inhibitor of PKC. (B) CKAR 
phosphorylation is specific for PKC. (Black) PKC is activated by 
200 nM PDBu and inhibited by 1 
 
 
 
M Go6983. (Red) Neither DMSO 
(vehicle for PDBu) nor 10 
 
 
 
M forskolin cause a change in FRET. 
(Green) Preinhibition of PKC (1 
 
 
 
M Go6983) does not change basal 
FRET, which remains unchanged by release of intracellular calcium 
by thapsigargin to stimulate other calcium-sensitive kinases such as 
CaMKII. (C) Supramaximal stimulation of PKC with 200 nM PDBu 
results in stable phosphorylation of CKAR, but inhibition of 
phosphatases with 100 nM calyculin A results in additional 
phosphorylation. Data are from two cells in the same field of view. 
(D) Phosphorylation of CKAR in the cytosol (red) and nucleus 
(black) reveal preferential cytosolic phosphorylation after PDBu 
but greater and uniform phosphorylation after calyculin A treatment. 
(E) Images corresponding to Fig. 2 D show phosphorylation (red 
shift of pseudocolored FRET ratio image, top) of CKAR after PDBu 
(20’) and PDBu and calyculin (40’). YFP intensity images (bottom) 
indicate no change in CKAR localization over the course of the 
experiment. (F) Mutation of the threonine phosphoacceptor in the 
designed PKC substrate of CKAR precludes FRET changes in response 
to either 200 nM PDBu or 100 nM calyculin. (G) CKAR is also 
sensitive to receptor-mediated activation of PKC. 10 
 
 
 
M histamine 
resulted in rapid phosphorylation of CKAR in HeLa cells. All data 
are representative of at least three experiments.T
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of PKC with 1 
 
 
 
M Gö6983 (Fig. 3 E) or mutation of the
phosphoacceptor threonine to alanine (Fig. 3 F) prevented a
FRET change upon stimulation with 10 
 
 
 
M histamine,
consistent with accurate reporting of phosphorylation by
MyrPalm-CKAR.
The striking rhythmicity of histamine-induced oscilla-
tions in substrate phosphorylation led us to explore whether
they reflected the well-characterized histamine-evoked cal-
cium oscillations in HeLa cells. We measured histamine-
evoked phosphorylation and Ca
 
2
 
 
 
 changes simultaneously
with MyrPalm-CKAR and the Ca
 
2
 
 
 
 indicator Fura red. Fig.
4 A shows that the oscillations in CKAR phosphorylation
(black line) are phase locked with Ca
 
2
 
 
 
 oscillations (red
line). Quantitative analysis of the peaks reveals that phos-
phorylation lags 
 
 
 
10–15 s behind Ca
 
2
 
 
 
 elevations (Fig. 4
B). To eliminate the possibility of spectral overlap from Fura
red causing illusory FRET changes in these experiments, we
measured histamine-induced calcium spikes with Fura red in
cells expressing the Thr to Ala mutant MyrPalm-CKAR and
saw almost no overlap of Fura red signal into the cyan and
yellow emission channels (Fig. 4 C). Although oscillations
are highly variable in HeLa cells, we noted that MyrPalm-
CKAR phosphorylation was always coupled to Ca
 
2
 
 
 
 (exam-
ined in at least 15 cells from eight separate experiments),
whether the Ca
 
2
 
 
 
 increases were regular, sustained oscilla-
tions, or brief, irregular transients.
In contrast to the oscillatory phosphorylation response of
membrane-tethered MyrPalm-CKAR, the data in Fig. 2 F
showed that response of cytosolic CKAR is not oscillatory.
Figure 3. Targeting CKAR to plasma membrane. (A) CKAR was 
targeted to plasma membrane by fusion of the 10 amino acid NH2 
terminus of the kinase Lyn to the NH2 terminus of CKAR, encoding 
myristoylation and palmitoylation. (Inset) An image of MyrPalm-
CKAR expressed in HeLa cells showing effective targeting of CKAR 
to the plasma membrane. (B) Supramaximal stimulation of PKC with 
200 nM PDBu results in nearly complete phosphorylation of CKAR, 
since inhibition of phosphatases with 100 nM calyculin A results 
in only slight additional phosphorylation. (C) MyrPalm-CKAR 
phosphorylation oscillates after 10  M histamine and is inhibited by 
1  M Gö6983. (D) Expanded time scale of Fig. 3 C. (E) Pretreatment 
with 1  M Gö6983 prevents MyrPalm-CKAR phosphorylation by 
10  M histamine. (F) Mutation of the threonine phosphoacceptor 
to alanine (T413A) makes MyrPalm-CKAR unresponsive to 10  M 
histamine. All data are representative of at least three experiments. 
Oscillatory phosphorylation, while highly variable, was detected 
in 10–20% of cells studied, observed in over 30 cells in more than 
12 different experiments.
Figure 4. MyrPalm-CKAR oscillatory phosphorylation corresponds 
to calcium oscillations. (A) Calcium (Fura red intensity, red) and 
MyrPalm-CKAR phosphorylation (CFP-YFP FRET, black) show 
that MyrPalm-CKAR phosphorylation corresponds directly to 
calcium transients. (B) Averaging the calcium and phosphorylation 
peaks in A illustrates a consistent lag of 10–20 s in MyrPalm-CKAR 
phosphorylation after initiation of calcium transients. The time 
of each Fura red intensity spike was normalized and the Fura red 
intensities and FRET ratios averaged for each image acquisition 
surrounding that fixed time. (C) Histamine stimulation of HeLa cells 
expressing MyrPalm-CKAR T413A shows that FRET changes are 
almost entirely independent of spectral overlap from Fura red signals 
and instead depend on the phosphoacceptor T413 in the PKC 
substrate of MyrPalm-CKAR. (D) Histamine stimulation resulting 
in calcium oscillations does not result in oscillatory phosphorylation 
of cytosolic CKAR. All data are representative of at least three 
experiments. Phase-locked calcium and phosphorylation oscillations 
have been noted in 15 different cells from eight experiments.T
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To confirm this result, we simultaneously measured CKAR
phosphorylation and Ca
 
2
 
 
 
 oscillations within the same cell.
Fig. 4 D shows that calcium-controlled oscillatory PKC
phosphorylation does not propagate through the cytosol
(Fig. 4 D). Thus, the balance between PKC and phos-
phatases oscillates only at the membrane, where PKC is
most active.
 
Correlation of activity with translocation
 
The preceding results show phase-locked oscillations of
PKC activity and calcium release. We next addressed
whether this Ca
 
2
 
 
 
-controlled activity reflected Ca
 
2
 
 
 
-con-
trolled membrane association or whether it reflected Ca
 
2
 
 
 
-
controlled changes in membrane affinity independent of dis-
sociation of PKC from the membrane. (Oancea and Meyer,
1998; Nalefski and Newton, 2001). To measure transloca-
tion in HeLa cells, we developed a novel FRET assay that
does not require complex optics such as total internal reflec-
tion fluorescence (Codazzi et al., 2001) or subjective dis-
crimination of membrane and cytosol regions in acquired
images (Oancea and Meyer, 1998). We fused the NH
 
2
 
-ter-
minus of Lyn kinase to mCFP to encode for myristoylation
and palmitoylation (MyrPalm-mCFP) and coexpressed this
with a PKC that had mYFP fused at both NH
 
2
 
- and
COOH-termini (Fig. 5 A). When PKC translocates from
the cytosol to the membrane upon generation of calcium
and DAG, the average distance between CFP and YFP de-
creases, causing increased FRET. YFP was fused to both
ends of PKC to increase the probability of FRET upon PKC
translocation. This method allows for whole cell monitoring
of PKC translocation to the site of MyrPalm-CFP. Fig. 5 B
shows that histamine stimulation of HeLa cells results in re-
petitive transient translocations (black line) that are phase
locked with calcium oscillations imaged with the fluorescent
dye Fura red (red line), consistent with a visible redistribu-
tion of mYFP-tagged PKC to membrane (unpublished
data). Oscillatory translocation was observed in the absence
of Fura red, indicating that FRET and not spectral overlap
from Fura red is responsible for the increase in measured yel-
low to cyan emission ratio (unpublished data).
 
Ca
 
2
 
 
 
 oscillations are uncoupled from 
diacylglycerol production
 
To explore whether DAG oscillates in phase with calcium,
we designed a probe for PLC activity. The most direct read-
out for DAG is translocation of the DAG-binding C1 do-
main (Oancea and Meyer, 1998). Unfortunately, GFP-
tagged C1 domains from PKC
 
 
 
, 
 
 
 
,
 
 
 
or 
 
 
 
 are insoluble in
HeLa cells and do not translocate effectively (unpublished
data). Instead, we took advantage of methodologies to detect
IP
 
3 
 
as a measure of PLC activity. As shown previously (Hi-
rose et al., 1999; van der Wal et al., 2001), the PH do-
main of PLC
 
 
 
, which binds phosphoinositide bisphosphate
(PIP
 
2
 
), translocates from the membrane to the cytosol upon
PLC activation and cleavage of PIP
 
2
 
. We adopted a novel
strategy to measure translocation of this PH domain that re-
ports translocation from membrane to cytosol upon PLC ac-
tivation. Fusion of both CFP and YFP to the PH domain of
PLC
 
 
 
 (cyan/yellow PH domain reporter [CYPHR]) allows
us to measure both intramolecular and intermolecular
FRET. Although changes in intramolecular FRET are un-
predictable, intermolecular FRET depends on the concen-
tration of fluorophore: because the effective concentration of
fluorophore is lower when diffusing in three-dimensional
cytosol than when diffusing in a two-dimensional mem-
brane, the dilution experienced by the PH domain upon
PLC activation is reported as a decrease in FRET (Fig. 6 A).
Decreased FRET corresponded to visible translocation from
membrane to cytosol (unpublished data).
CYPHR expressed in HeLa cells reports a sustained PLC
activity during histamine-evoked calcium oscillations (Fig. 6
B), implying a calcium-induced calcium release (CICR)
Figure 5. Histamine induces oscillations of PKC translocation. 
(A) YFP fused to both termini of PKC functions as a FRET acceptor 
for CFP fused to the myristoylation and palmitoylation sequence from 
Lyn (MyrPalm-CFP). Translocation of YFP-PKC-YFP to a membrane 
containing MyrPalm-CFP results in increased FRET. (B) Addition of 
10  M histamine to HeLa cells causes rapid, oscillating translocation 
of YFP-PKC-YFP to plasma membrane (black) corresponding to 
oscillating calcium transients imaged by Fura red in the same cell 
(red). Data are representative of three experiments.
Figure 6. Translocation of the PH domain of PLC  reported by 
FRET reveals constant PLC activity during calcium oscillations. (A) 
CYPHR, a CFP-PH -YFP fusion construct, reports PLC activity by re-
duced intermolecular FRET upon translocation from membrane. The 
PH domain of PLC 1, which binds PIP2 in the plasma membrane, 
translocates to cytosol upon PIP2 hydrolysis. Translocation from mem-
brane (two dimensions) to cytosol (three dimensions) results in a de-
creased effective concentration and hence lower intermolecular 
FRET. (B) CYPHR reports constant PLC activity (black) during cal-
cium oscillations (red). Data are representative of four experiments.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 
 
 
Oscillatory phosphorylation by PKC |
 
 Violin et al. 905
 
mechanism of oscillation instead of dynamic uncoupling.
This is consistent with earlier reports of the insensitivity of
histamine-evoked calcium oscillations in HeLa cells to IP
 
3
 
concentration (Sauve et al., 1991) and contrasts with sys-
tems showing phase-locked oscillations of IP
 
3
 
 and calcium
(Hirose et al., 1999; Nash et al., 2001). Indeed, a GFP-
tagged PH domain exhibits oscillatory translocation in phase
with ATP-evoked calcium oscillations in MDCK cells, an
example of the dynamic uncoupling mechanism of oscillat-
ing PLC activity (Hirose et al., 1999). Consistent with these
findings, MyrPalm-CKAR, DAG reporter, (DAGR; identi-
cal to CYPHR but with a PKC
 
 
 
 C1 domain replacing the
PH domain), and CYPHR report transient responses of
phosphorylation, DAG, and PLC activity phase locked with
calcium transients in MDCK cells (Fig. 7, A–C). DAGR vis-
ibly translocated from cytosol to membrane upon ATP stim-
ulation or PDBu addition to MDCK cells (unpublished
data), consistent with its characterization as a DAG sensor
(Oancea et al., 1998) This differs markedly from histamine-
evoked oscillations of phosphorylation in HeLa cells in
 
which PLC activity reported by CYPHR is independent of
calcium transients. We conclude that histamine-evoked
PKC responses in HeLa and ATP-evoked PKC responses in
MDCK cell represent two distinct mechanisms for temporal
control of PKC activation.
 
Discussion
 
The foregoing results underscore the importance of spa-
tiotemporal control of second messengers and their signaling
systems. Specifically, using a genetically engineered reporter
for monitoring the activity of endogenous PKC, we show
that substrate phosphorylation is under the dynamic control
of second messenger levels, which directly regulate the intrin-
sic activity of PKC, and cellular phosphatase activity, which
rapidly terminates signaling by PKC. We show that in HeLa
and MDCK cells, histamine and ATP trigger sustained oscil-
latory phosphorylation of membrane-tethered reporter and
that these oscillations are phase locked with Ca
 
2
 
 
 
 oscillations.
 
CKAR: specific reporter for the dynamic interplay 
between phosphorylation and dephosphorylation 
of PKC substrates
CKAR was successfully designed to be a specific, reversible
reporter of phosphorylation by PKC (Figs. 1 and 2). Speci-
ficity was achieved by de novo design of a substrate sequence
using information from oriented peptide library screens
identifying determinants that dictate kinase substrate speci-
ficity (Yaffe et al., 2001). Reversibility was achieved by
choosing an FHA2 domain to bind phosphothreonine with
modest affinity (10  M) (Durocher et al., 2000).
PKC translocation, CYPHR, and DAGR
We also devised new FRET-based reporters for PKC trans-
location, PIP2 to IP3 hydrolysis, and diacylglycerol. These
reporters not only translocate to and from the plasma mem-
brane but also alter the ratio of yellow to cyan emissions in
response to the appropriate signals. These indicators may
have significant value in flow cytometry, complex tissues, or
high throughput screening, where quantitative monitoring
of translocation of a GFP-tagged C1 domain, PKC, or PH
domain to the plasma membrane is difficult.
Subcellular specificities of CKAR phosphorylation
We found that CKAR is only partially phosphorylated in
vivo when localized to the cytosol, even with maximal activa-
tion of PKC by phorbol esters (Fig. 2 C). Presumably, this
phosphorylation arises from diffusional collision of CKAR
with PKC at the membrane, where it becomes phosphory-
lated and then diffuses back into the cytosol. The lower level
of phosphorylation seen in the nucleus (Fig. 2, D and E) in-
dicates a different balance of kinase and phosphatase there,
either through impaired accessibility to active PKC or higher
nuclear phosphatase activity. This is consistent with nuclear
exclusion noted for most PKC isoforms (Shirai et al., 1998a;
Kajimoto et al., 2001). In contrast, targeting CKAR to the
plasma membrane, the site of activation of PKC, results in
nearly complete phosphorylation of the reporter as revealed
by the minimal effect of phosphatase inhibition on the phos-
Figure 7. PLC controls oscillations of PKC activity in MDCK cells. 
10  M ATP induces calcium transients phase locked with responses 
of MyrPalm-CKAR (reports phosphorylation) (A), CYPHR (reports PLC 
activity) (B), and DAGR (reports DAG) (C). All data are representative 
of three to five experiments.T
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phorylation of membrane-tethered CKAR (Fig. 3 B). This
likely reflects the increased probability of phosphorylating a
substrate colocalized with PKC. These data indicate a spatial
gradient in the balance between kinase and phosphatase more
favorable for phosphorylation at the plasma membrane than
in the cytosol, and more favorable in the cytosol than in the
nucleus. Such radial gradients were predicted some time ago
(Brown and Kholodenko, 1999) but were not observable un-
til the advent of genetically encoded phosphorylation report-
ers. It is interesting in this regard that not only is there an
abundance of kinases tethered to their substrates (Jaken and
Parker, 2000), but also there is a growing number of scaffolds
that tether both a phosphatase and a kinase in the same com-
plex (Coghlan et al., 1995; Westphal et al., 1998).
Calcium oscillations dictate substrate phosphorylation 
by conventional PKCs
HeLa cells, like many electrically nonexcitable cell types, un-
dergo repetitive cycles of calcium release and reuptake upon
stimulation with some agonists, resulting in periodic spikes
of free intracellular calcium. Conventional isoforms of PKC
can translocate in phase with these spikes, leading to an os-
cillatory translocation, ostensibly producing bursts of PKC
activity (Oancea and Meyer, 1998; Tanimura et al., 2002).
However, it was not known if PKC-mediated substrate
phosphorylation and phosphatase activity were kinetically
competent to result in distinct spikes of phosphorylation
during individual calcium oscillations. We find that when
CKAR is targeted to plasma membrane by acylation (Fig. 3),
regular, pulsatile phosphorylation oscillations occur in phase
with calcium oscillations (Fig. 4).
Oscillations in PKC activity that are phase locked with
calcium oscillations can occur either through a predomi-
nantly calcium-mediated activation of conventional PKC
isozymes or through concurrent oscillations in DAG and
calcium. Although the first of these possibilities is consistent
with any model of calcium oscillations, the second is incon-
sistent with CICR (Harootunian et al., 1991; Thomas et al.,
1996; Nash et al., 2001), which postulates no feedback of
calcium to PLC activity and thus does not predict nor ac-
count for oscillations of DAG and IP3. Instead, a model of
concurrently oscillating calcium and DAG implies an oscil-
lator mechanism in dynamic uncoupling of receptor occupa-
tion from PLC activity (Harootunian et al., 1991; Hirose et
al., 1999). These distinct modes of calcium oscillation are
proposed to constitute disparate signals transduced by the
same PLC-mediated pathway (Nash et al., 2001).
Previous work has shown oscillatory conventional PKC
translocation during both CICR (Oancea and Meyer, 1998)
and dynamic uncoupling (Codazzi et al., 2001) mediated
calcium oscillations as evidenced by sustained and oscillating
DAG, respectively. Although we are unable to measure
DAG directly in HeLa cells, our results are consistent with a
CICR mechanism of calcium oscillation since PLC activity
does not oscillate (Fig. 6), in agreement with previous results
(Sauve et al., 1991) and inconsistent with oscillations of
DAG. We nevertheless noted oscillatory PKC translocation,
consistent with a requirement for both calcium and DAG
for maximal membrane binding (Fig. 5); active PKC at
membranes at least partially translocates to cytosol upon cal-
cium reuptake, since DAG alone cannot maintain full PKC
membrane affinity. It is important to note that translocation
does not directly reflect activation, since weakly membrane-
bound PKC is not fully active (Orr and Newton, 1992;
Newton and Keranen, 1994; Johnson et al., 2000). Thus, in
contrast to previous work showing such calcium-controlled
PKC activity, we now have a direct readout of PKC sub-
strate phosphorylation. The revelation of oscillatory sub-
strate phosphorylation indicates a high temporal fidelity for
PKC signals: changes in PKC activation are rapidly trans-
duced to substrate phosphorylation or dephosphorylation by
a close coupling of PKC and phosphatases. This temporal
specificity is evident only when CKAR is targeted to mem-
branes, since a cytosolic CKAR does not experience oscilla-
tory phosphorylation even in the presence of calcium oscilla-
tions (Fig. 6 D). This is most likely because PKC activity is
membrane limited, allowing for enhanced phosphorylation
of a membrane-bound substrate; a cytosolic substrate must
rely on diffusion to membrane-bound PKC to become phos-
phorylated. Only a tight spatial coupling of kinase, phos-
phatase, and substrate allows such remarkably high temporal
fidelity of phosphorylation signals.
An intriguing corollary of this result is the possibility of
temporal PKC isoform specificity. In both CICR and dy-
namic uncoupling, DAG is present when cytosolic calcium
is elevated, so conventional PKC oscillations are indepen-
dent of DAG. In contrast, novel PKC isoforms, unrespon-
sive to calcium, may differentiate between sustained and
oscillatory DAG. Thus, novel PKCs are equipped to dis-
criminate CICR from dynamic uncoupling. However, with-
out the advantage of a calcium-enhanced search for DAG
(Nalefski and Newton, 2001), it is unknown if novel PKC’s
respond fast enough to maintain temporal fidelity of DAG
oscillations. It will be important to test each PKC isoform
for oscillatory translocation in both CICR and dynamic un-
coupling calcium oscillations to illuminate differences in the
temporal signals of individual PKC isoforms.
It is widely accepted that the outcome of PKC activity de-
pends on the amount and duration of activation, but the im-
portance of oscillatory phosphorylation is unclear. Such oscil-
lations may be a mechanism of encoding signal specificity, or
they may be a necessary consequence of calcium oscillations,
unrelated to effects downstream of PKC. However, calcium
oscillations increase both the sensitivity and specificity of cal-
cium signals (De Koninck and Schulman, 1998; Dolmetsch
et al., 1998; Li et al., 1998), setting precedent for such tem-
poral decoding by the cell. As tools and techniques become
available to better identify and assay the phosphorylation of
physiological substrates of PKC, it will be important to eval-
uate if the same is true of oscillatory phosphorylation.
Molecular mechanism for Ca
2 -controlled 
PKC activation
Fig. 8 shows a model for the molecular control of PKC ac-
tivity by second messengers based on previous studies (New-
ton, 2001) that accounts for the Ca
2 -controlled oscillations
in substrate phosphorylation found in histamine-stimulated
HeLa cells and PLC-controlled oscillations found in MDCKT
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cells. In the absence of lipid hydrolysis, PKC is localized pri-
marily to the cytosol (Fig. 8, 1) where it is maintained in an
inactive conformation by the pseudosubstrate (green rectan-
gle) which occupies the substrate-binding cavity, sterically
blocking substrate phosphorylation. In vitro studies show
that this autoinhibited species does have modest basal activ-
ity (an order of magnitude less than maximal cofactor-stim-
ulated activity), so cellular phosphatase activity likely plays a
key role in rapidly abolishing any basal phosphorylation.
This species of PKC bounces on and off the membrane by a
diffusion-controlled mechanism but is not retained on the
membrane in the absence of the appropriate second messen-
gers. Generation of Ca
2  and DAG through receptor-medi-
ated mechanisms results in the recruitment of PKC to the
membrane by the following mechanism: Ca
2  binds the C2
domain of cytosolic PKC (Fig. 8, 2), altering the electrostat-
ics of this module so that upon the next encounter with the
membrane the C2 domain binds anionic lipids and PKC is
tethered to the membrane by a low affinity interaction (Fig.
8, 3). This species of PKC then diffuses in the two-dimen-
sional plane of the membrane until it finds DAG, which
then binds the C1 domain, resulting in a high affinity inter-
action of PKC with the membrane (Fig. 8, 4). The energy
provided by engaging both these modules on the membrane
releases the basic pseudosubstrate from the acidic substrate-
binding cavity, allowing substrate binding and phosphoryla-
tion. Loss of either membrane tether through a decrease in
either Ca
2  or DAG results in a decrease in the affinity of
PKC for membranes (Fig. 8, 5). If this decrease in affinity is
significant, PKC is released from the membrane; however, it
is also possible that it is retained at the membrane but via
only one of the membrane-targeting modules. Importantly,
loss of one anchor results in loss of the binding energy re-
quired to maintain the pseudosubstrate away from the active
site, and the enzyme regains the autoinhibited conforma-
tion. This pause in PKC activity allows phosphatase activity
to dominate, resulting in substrate dephosphorylation. Ele-
vation of Ca
2  allows the C2 domain to engage on the mem-
brane again, favoring release of the pseudosubstrate to allow
renewed substrate phosphorylation. Thus, the oscillations in
PKC activity observed arise from altering the equilibrium of
the pseudosubstrate blocking the substrate-binding cavity.
This molecular rearrangement is controlled by how tightly
the C1 and C2 domains are engaged on the membrane,
events which, in turn, are controlled by the levels of DAG
and Ca
2 , respectively. As a coincidence detector for these
messengers, PKC is temporally controlled by whichever
messenger is regulated the most rapidly. In the case of hista-
mine treatment of HeLa cells, Ca
2  oscillations and not
DAG oscillations dictate this allosteric regulation of PKC,
whereas in ATP-stimulated MDCK cells, Ca
2  and DAG
oscillate together.
Conclusion
In this study, we show that PKC-mediated phosphorylation
signals depend on the spatiotemporal context of second mes-
sengers, kinase, substrate, and phosphatase. Specifically, we
find that the phosphorylation state of the reporter CKAR re-
flects coincidence of the second messengers calcium and
DAG that together activate PKC. Tight spatial coupling of
kinase and phosphatase activities allows for highly dynamic
phosphorylation: when CKAR is tethered to membranes, its
Figure 8. A model of the temporal control of PKC signals. Inactive, cytosolic PKC is autoinhibited by a pseudosubstrate (1). Phospholipase 
activation results in DAG formation and calcium release: calcium binds cytosolic PKC (2), imparting weak membrane affinity (3). Calcium-
bound PKC rapidly binds DAG in the membrane, resulting in maximal membrane affinity and full PKC activity by removal of the pseudosubstrate 
from the active site (4). A drop in either calcium or DG results in decreased membrane affinity and reinhibition by the pseudosubstrate (5). 
This coincidence detection by PKC defines a signaling nexus in the cell, whereby strict temporal fidelity of phosphorylation is dictated by 
rapid turnover of either second messenger and counterbalancing phosphatase activity.T
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phosphorylation is phase locked with calcium oscillations in
both HeLa and MDCK cells, independent of constant
(HeLa) or oscillating (MDCK) DAG generation. This tem-
poral fidelity of the PKC signal pathway, from second mes-
senger to substrate phosphorylation, allows precise control
of cellular regulation by creating high temporal bandwidth
for PKC signals and is likely to be of critical importance to
many cellular processes.
Materials and methods
CKAR construction
CKAR was generated in the mammalian expression vector pcDNA3.1( )
(Invitrogen). CFP was amplified by PCR from a plasmid template to encode
a HindIII restriction site followed by a consensus initiation site for translation
(CGCCACC) (Kozak, 1987) before the initiating ATG of CFP, and a KpnI re-
striction site at the 3  end instead of a terminating codon. FHA2, a gift from
Michael Yaffe (Massachusetts Institute of Technology, Cambridge, MA) was
amplified by PCR to include KpnI and BamHI restriction sites at the 5  and
3  ends, respectively. Citrine, our preferred version of YFP (Griesbeck et al.,
2001), was amplified by PCR to include a 5  BamHI followed by the PKC
substrate sequence and a 3  XbaI following the terminating codon. These
pieces were cloned into pcDNA3.1 and confirmed by sequencing.
A parallel construct was made including the mutation A206K in both
CFP (mCFP) and citrine (mYFP) to reduce the intrinsic homoaffinity of all
GFPs (Zacharias et al., 2002) and preclude intermolecular FRET by CFP-
mYFP dimerization. This construct was shown to function as well as the
original CKAR and so was used for all experiments. For in vitro experi-
ments, CKAR was amplified to include a 5  BglII site and a 3  SalI site and
cloned into pRSETB (Invitrogen) cut from BamHI to XhoI. MyrPalm-CKAR
was generated by the addition of a HindIII restriction site, a consensus
translational initiation site, and the 5  30 bp of Lyn kinase to the 5  end of
CKAR. This sequence encodes for myristoylation and palmitoylation,
shown previously to be sufficient to target a protein to the plasma mem-
brane (Zacharias et al., 2002).
Construction of other plasmids
MyrPalm-CFP was made by PCR with the same 5  primer as used for Myr-
Palm-CKAR and a 3  primer to the COOH terminus of CFP with an Xba
site and cloned into pcDNA3.1( ). YFP-PKC II-YFP was made by PCR of
mYFP from HindII to KpnI, rat PKC II from KpnI to XhoI, and YFP from
XhoI to XbaI, cloned sequentially into pcDNA3.1( ). CYPHR was gener-
ated by PCR of CFP from HindIII to KpnI, the PH domain of murine PLC 1
(aa 10–140) from KpnI to XhoI, and mYFP from XhoI to XbaI cloned se-
quentially into pcDNA3.1( ).DAGR was similarly created by PCR of the
C1A and C1B domains of rat PKC II (aa 37–152) from KpnI to XhoI and
substitution for the PH domain in CYPHR.
Protein expression, kinase assays, and in vitro spectroscopy
CKAR in the pRSETB vector was transformed into BL21 Gold Escherichia
coli (Stratagene) and purified by nickel chelation chromatography as de-
scribed previously (Miyawaki and Tsien, 2000). Protein yield was esti-
mated by CFP absorption at 434 nm. Fluorescence emission spectra were
measured with an excitation wavelength of 434 nm.
For kinase assays, CKAR (125 nmol) was incubated with purified PKC II
(1 U  L
 1), PKA (5 U  L
 1), or CamKII (5 U  L
 1) with appropriate buffers
and cofactors including [ -
32P]ATP (100  M, 10  Ci) as described earlier
for PKC (Newton, 2002a) or in the manufacturers’ instructions for PKA and
CamKII (New England Biolabs, Inc.) for varying amounts of time. Proteins
were separated by SDS-PAGE, stained with Coomassie blue, bands corre-
sponding to CKAR excised, and 
32P incorporation measured by scintilla-
tion counting. Fluorescence emission scans were obtained from samples
phosphorylated in parallel with unradiolabeled ATP with excitation at 434
nm to excite CFP.
Cell culture
HeLa and MDCK cells were plated onto sterilized glass coverslips in 35-
mm dishes and grown in DME containing 10% FBS at 37 C with 5% CO2.
At 60–80% confluency, cells were transfected with either Superfect or Poly-
fect (QIAGEN) and allowed to grow for 12–24 h posttransfection before im-
aging. For calcium imaging experiments, 0.2–1.0  M Fura red/AM or Fura-
2/AM (Molecular Probes) was loaded into cells for 30 min, washed once
with PBS, and incubated for 30–60 min in fresh media before imaging.
Cell imaging
Cells were washed once with HBSS and imaged in the dark at room tem-
perature. Images were acquired on a Zeiss Axiovert microscope (Carl Zeiss
MicroImaging, Inc.) with a cooled charge-coupled device camera (Photo-
metrics) controlled by MetaFluor 3.0 software (Universal Imaging, Corp).
CFP, FRET, and Fura red images were obtained through a 440DF20 excita-
tion filter, a 455DRLP dichroic mirror, and three separate emission filters
(480DF30 for CFP, 535DF25 for FRET, and 653DF95 for Fura red). Citrine
intensity was imaged through a 495DF10 excitation filter, 455DRLP di-
chroic mirror, and 535DF25 emission filter. Excitation and emission filters
were switched in filter wheels (Lambda 10–2; Sutter). Integration times
were varied between 200 and 500 ms to optimize signal and minimize
photobleaching. Optical filters were obtained from Chroma Technologies
and Omega Optical. Because Fura red emission overlaps Citrine/FRET
emission, care was taken to limit the amount of Fura red loaded. Measure-
ments were restricted to cells in which CKAR expression was high enough
to be unaffected by changes in Fura red intensity.
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